5000124430504

The barcode 5000124430504 corresponds to the GlaxoSmithKline PLC product "Beconase Aqueous Nasal Spray 50mcg/200mL". This is a prescription-only medication, also available for over-the-counter (OTC) purchase in some regions, utilized primarily for alleviating nasal congestion due to allergies.

Beconase Aqueous Nasal Spray contains azelastine hydrochloride, which is an antihistamine that effectively reduces swelling in the nasal passages, providing relief from symptoms associated with allergic rhinitis. The medication is delivered directly into the nostrils using a metered dose inhaler (MDI), ensuring accurate dosing with each application.

Warnings associated with Beconase Aqueous Nasal Spray include the potential for allergic reactions, such as skin rashes, itching, and difficulty breathing. This product is contraindicated in patients with a history of severe allergic reactions or asthma due to the risk of exacerbating these conditions.

Pricing can vary by location, pharmacy, and supply availability. In the United States, a 30-day supply typically ranges from $20 to $50. In the UK, this product is available by prescription with a price range of approximately £10 to £30 (around $13 to $40 USD) for a single bottle.

Given that Beconase Aqueous Nasal Spray is a consumable product, several health-related disclaimers apply, including:

• Individuals with a history of severe allergic reactions or asthma should not use this medication.
• Caution is advised for patients with nasal polyps, high blood pressure, or existing heart disease.
• Pregnant or breastfeeding women should avoid using this nasal spray.

Users are advised to follow the instructions provided on the product label and consult healthcare professionals if any concerning symptoms or side effects occur during use.